Figure 2.
NO and PDE5 inhibitors control cGMP levels, thereby lowering vascular pressure. NO binds Scheme 5. which is responsible for hydrolysis of cGMP. NO, nitric oxide; PDE5, phosphodiesterase-5; cGMP, cyclic guanosine monophosphate.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.